By The Registry Staff A Bellevue-based biotech firm, Viome Life Sciences, continues its upward trajectory, securing an additional $19.5 million in its Series C financing, bringing the total for this round to $86.5 million. This recent closure of the funding round comes on the heels of its initial $67 million raise in October, and the […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
EQT AB, whose real estate arm has steadily accumulated industrial assets from...
ByThe RegistryOctober 15, 2026Portland State University has opened the $90 million home of its Schnitzer...
ByThe RegistryOctober 15, 2026CenterPoint Properties has leased its 4.16-acre, rail-served outdoor storage yard at 2021...
ByThe RegistryOctober 15, 2026National Institutes of Health funding to Seattle-area researchers slipped to $1.2 billion...
ByThe RegistryOctober 15, 2026